2nd Quarter - Report

INVARIANT LLC for EMULATE, INC.

Period 2nd Quarter 2020 Filed Jul 20, 2020 Signed by Laura Joshua

Official filing
Firm
INVARIANT LLC
Client
EMULATE, INC.
Income
$90,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Introduce Emulate's technology to policymakers and discuss their work on COVID-19.

LobbyistCovered position, as disclosed
BENJAMIN KLEIN —
KATHRYN WISE —

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Defense DEF

Support funding for using Emulate's platform to detect aerosolized threats to protect the war fighter, including language in S.4049 / H.R. 6395, the National Defense Authorization Act for Fiscal Year 2021.

LobbyistCovered position, as disclosed
BENJAMIN KLEIN —
LINDLEY SHERER —
KATHRYN WISE —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 4049 (116th), H.R. 6395 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.